R547
Catalog No. A11190
R547是一种新型的细胞周期和转录周期依赖性激酶(CDKs)选择性抑制剂(CDK1,CDK2和CDK4分别为Ki = 1、3和1 nM),具有出色的体外细胞效价,可抑制各种细胞的生长。人肿瘤细胞系。
Catalog Num | A11190 |
---|---|
M. Wt | 441.45 |
Formula | C18H21F2N5O4S |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 741713-40-6 |
Synonyms | R-547 |
SMILES | COC1=C(C(=C(C=C1)F)F)C(=O)C2=CN=C(N=C2N)NC3CCN(CC3)S(=O)(=O)C |
R547是一种新型的细胞周期和转录周期依赖性激酶(CDKs)选择性抑制剂(CDK1,CDK2和CDK4分别为Ki = 1、3和1 nM),具有出色的体外细胞效价,可抑制各种细胞的生长。人肿瘤细胞系。
Targets
Target | Value |
---|---|
CDK4/CyclinD1 | ki: 1nM |
CDK1/CyclinB | ki: 2nM |
CDK2/CyclinE | ki: 3nM |
PKA | ki: >5μM |
PKB | ki: >5μM |
PKCα | ki: >5μM |
PKCβ | ki: >5μM |
Fyn | ki: >5μM |
EphB3 | ki: >5μM |
SGK | ki: >5μM |
KDR | ki: >5μM |
FGFR | ki: >5μM |
EGFR | ki: >5μM |
PDGFR | ki: >5μM |
IGFR | ki: >5μM |
Src | ki: >5μM |
FAK | ki: >5μM |
AuroraA | ki: >5μM |
GSK-3β | ki: 8μM |
p38 | ki: >50μM |
MAPK2 | ki: >50μM |
In vitro (25°C) | DMSO | 56 mg/mL (126.85 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 1% hydroxyethyl cellulose+0.2% Tween 80 | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.65 mL | 113.26 mL | 226.53 mL |
0.5 mM | 4.53 mL | 22.65 mL | 45.31 mL |
1 mM | 2.27 mL | 11.33 mL | 22.65 mL |
5 mM | 0.45 mL | 2.27 mL | 4.53 mL |
*The above data is based on the productmolecular weight 441.45. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.